2026-04-17T20:09:10Zhttps://recercat.cat/oai/requestoai:recercat.cat:11351/124392025-10-24T10:38:25Zcom_2072_378070com_2072_378040col_2072_378092
2025-10-24T10:38:25Z
urn:hdl:11351/12439
Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma
Di Staso, Rossana
Casadei, Beatrice
Locke, Frederick
Voorhees, Timothy
Kittai, Adam
Jain, Michael
Barba, Pere
IACOBONI, GLORIA
Cèl·lules T
Cèl·lules B - Tumors - Immunoteràpia
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunization, Passive::Adoptive Transfer::Immunotherapy, Adoptive
DISEASES::Neoplasms::Neoplasms by Histologic Type::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, B-Cell::Lymphoma, Large B-Cell, Diffuse
Other subheadings::Other subheadings::Other subheadings::/drug therapy
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia::inmunización::inmunización pasiva::transferencia adoptiva::inmunoterapia adoptiva
ENFERMEDADES::neoplasias::neoplasias por tipo histológico::linfoma::linfoma no Hodgkin::linfoma de células B::linfoma de células B grandes difuso
Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia
CAR-T cells; Diffuse large B cell lymphoma
Células CAR-T; Linfoma difuso de células B grandes
Cèl·lules CAR-T; Limfoma difús de cèl·lules B grans
Funding was provided by Alma Mater Studiorum- University of Bologna (ID grant: ALMA IDEA 2022 CUP:J33C22001420001). We thank Massimo Agostini for data entry and AIL Bologna OdV (prot 2CSAIL21 Argnani).
2025-10-24T10:38:25Z
2025-10-24T10:38:25Z
2025-01-20T10:08:02Z
2025-01-20T10:08:02Z
2024-11-07
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://hdl.handle.net/11351/12439
Blood Cancer Journal;14
https://doi.org/10.1038/s41408-024-01183-8
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
Springer Nature
Scientia